Pharmaceutical Combination comprising a compound selected from anticancer TAXOTERE (docetaxel), (R)Vincristine and doxorubicin in combination with Combretastatin useful in the treatment of Solid tumors.

摘要

It provides an antitumor Combination comprising a stilbene derivative and an anticancer Compound selected from the group consisting of taxanes, alkylating agents,Antimetabolites, epodofilotoxinas Vinca alkaloids, Antibiotics, and as an active ingredient.It also provides methods for using these Pharmaceutical preparations in the treatment of Solid carcinomas and similar.